Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone and Ibuprofen for Postoperative Edema in Third Molar Surgery
NCT05941130Phase 4Unknown
- Sponsor
- Implantology Institute
- Start
- Jul 2022
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of methylprednisolone in edema and postoperative pain (2 arms), sponsored by Implantology Institute. Primary endpoint: Facial swelling at 7 days. Status: unknown.
02
Drugs
methylprednisolone
03
Conditions
edemapostoperative pain
Beyond the preview
Go deeper on NCT05941130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05941130.